NDC 50102-120-01 - AUBRA
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50102-120
- Requested NDC
- 50102-120-01
- Package NDCs from labels
- 50102-120-00, 50102-120-01, 50102-120-48, 50102-120-10, 50102-120-03
- Manufacturer
- Afaxys Pharma, LLC | Mylan Laboratories Limited
- Effective date
- 2021-01-25
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| AUBRA - Afaxys Pharma, LLC | Mylan Laboratories Limited | Afaxys Pharma, LLC | Mylan Laboratories Limited | 2021-01-25 | HUMAN PRESCRIPTION DRUG LABEL |
| Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) | RPK Pharmaceuticals, Inc. | 2020-12-15 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 50102-120-03 | 2023-02-17 | Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) |
| 50102-120-48 | 2023-02-17 | Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) |
| 50102-120-03 | 2023-01-30 | Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) |
| 50102-120-48 | 2023-01-30 | Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50102-120-00 | EA - Each | 50102-120 | d9bee6d9-aa9d-4898-93de-438dae2bb869 | 1 | 2022-06-06 |
| 50102-120-01 | EA - Each | 50102-120 | 8b796782-496f-4ed0-b025-66127b0fc3f9 | 1 | 2013-11-04 |
| 50102-120-03 | EA - Each | 50102-120 | c2265cdf-ed8f-437d-9e4b-312af0119f71 | 1 | 2017-09-11 |
| 50102-120-10 | EA - Each | 50102-120 | 5c1fb698-e254-4b92-8ed9-eb87d3604632 | 1 | 2017-09-11 |
| 50102-120-48 | EA - Each | 50102-120 | 8a66d499-33ea-4443-a859-d114a3240255 | 1 | 2013-11-04 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Household Antigens | ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, BUTYL ACETATE, ETHYL ACETATE, TOLUENE, XYLENE, BISPHENOL A, PETROLEUM, ANACARDIUM ORIENTALE, GRAPHITES, NITRICUM ACIDUM, PULSATILLA (PRATENSIS), SULPHUR | Energique, Inc. | 87c92497-8a51-4977-87fe-e0b4c6bafb19 | 2024-09-27 | Warnings | 368GB5141J |
| Calamine | CALAMINE AND ZINC OXIDE | Strategic Sourcing Services, LLC | 22173332-9d09-768c-e063-6394a90a94e1 | 2024-09-14 | Warnings | 1K09F3G675 |
| Levonorgestrel | LEVONORGESTREL | Ohm Laboratories Inc. | 5c509934-8c11-4d7f-8506-5971c37cfc22 | 2024-09-06 | Warnings | 5W7SIA7YZW |
| Etonogestrel and Ethinyl Estradiol Vaginal Ring | ETONOGESTREL AND ETHINYL ESTRADIOL VAGINAL RING | Northstar Rx LLC | 1488f5ae-3b34-fcd7-6049-215929b1d324 | 2024-06-24 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| EnilloRing | ETONOGESTREL AND ETHINYL ESTRADIOL VAGINAL | Xiromed, LLC | 85a126f6-d3e0-9e12-73f9-6176ba36f58b | 2024-06-24 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Calamine | FERRIC OXIDE RED | NuCare Pharmaceuticals,Inc. | 66e98554-e158-a519-e053-2a91aa0a6783 | 2024-06-06 | Warnings, Adverse reactions | 1K09F3G675 |
| My Way | LEVONORGESTREL | NuCare Pharmaceuticals,Inc. | 6598a875-8be8-0928-e053-2a91aa0a064d | 2024-06-06 | Warnings | 5W7SIA7YZW |
| Enviroclenz | BERBERIS VULGARIS, CARDUUS MARIANUS, CHELIDONIUM MAJUS, GLYCYRRHIZA GLABRA, LAPPA MAJOR, RHAMNUS FRANGULA, STILLINGIA SYLVATICA, TARAXACUM OFFICINALE, TRIFOLIUM PRATENSE, GERMANIUM SESQUIOXIDE, PHYTOLACCA DECANDRA, ACETONE, AMMONIUM MURIATICUM, BENZINUM, PROPYLENE GLYCOL, SODIUM LAURYL SULFATE, SODIUM TRIPOLYPHOSPHATE, TEREBINTHINA, METHANOL, CHLORINUM, IRIDIUM METALLICUM, LYCOPODIUM CLAVATUM, NITRICUM ACIDUM, NUX VOMICA, PHOSPHORICUM ACIDUM | Deseret Biologicals, Inc. | 92816bbe-96d6-45fc-9929-d3e6df394a33 | 2024-05-02 | Warnings | 368GB5141J |
| Envirotox | TRITICUM AESTIVUM, BERBERIS VULGARIS, LAPPA MAJOR, RHAMNUS PURSHIANA, SENNS (CASSIA ANGUSTIFOLIA), PHYTOLACCA DECANDRA, GLYCYRRHIZA GLABRA, STILLINGIA SYLVATICA, TRIFOLIUM PRATENSE, XANTHOXYLUM FRAXINEUM, ACETONUM ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, BELLADONNA, LYCOPODIUM CLAVATUM, NITRICUM ACIDUM, NUX VOMICA, PHOSPHORICUM ACIDUM, BELLADONNA, LYCOPODIUM CLAVATUM, NITRICUM ACIDUM, NUX VOMICA, PHOSPHORICUM ACIDUM. | BioActive Nutritional, Inc. | 2b5cfdba-cf4d-4eb0-8c60-20eac6922663 | 2024-03-26 | Warnings | 368GB5141J |
| NUVARING | ETONOGESTREL AND ETHINYL ESTRADIOL | A-S Medication Solutions | e14bc197-dd22-4e6e-8aa1-d6cf2242fe0f | 2024-03-10 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Jinteli | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | Teva Pharmaceuticals USA, Inc. | d667ca75-1a17-43fc-9077-f25ce0908f8d | 2024-02-27 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| XULANE | NORELGESTROMIN AND ETHINYL ESTRADIOL | A-S Medication Solutions | adcf17ef-e60b-48a4-9478-3998dab2bbbd | 2024-02-27 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | Mylan Pharmaceuticals Inc. | 3108a9bc-3378-459d-8f6b-bd5eff2ad657 | 2024-01-15 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | Mylan Pharmaceuticals Inc. | 89948751-bd6e-4e9c-b87c-8782706c1097 | 2024-01-15 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| ZAFEMY | NORELGESTROMIN AND ETHINYL ESTRADIOL | Bryant Ranch Prepack | 77230a20-4269-4abf-ae2a-ac5ccafef565 | 2024-01-05 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Etonogestrel/Ethinyl Estradiol | ETONOGESTREL AND ETHINYL ESTRADIOL | A-S Medication Solutions | fcf9da2a-bb91-4697-bfaa-c9d58855e275 | 2023-11-22 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Aurovela 1.5/30 | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | Aurobindo Pharma Limited | b146e49c-a0fc-4f3d-9ad6-99e8257fa139 | 2023-11-21 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| PostDay One-Step | LEVONORGESTREL | Rapha Pharmaceuticals, Inc. | 6f7f5697-acb6-ea95-e053-2991aa0ae7c7 | 2023-11-21 | Warnings | 5W7SIA7YZW |
| Aurovela 1/20 | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | Aurobindo Pharma Limited | 6765becf-7b51-4f33-ac13-70fcd01decf7 | 2023-11-21 | Warnings, Adverse reactions | 423D2T571U |
| Plan B One-Step | LEVONORGESTREL | A-S Medication Solutions | fcc7ba8e-ad54-4efe-87e4-5eb0fbf4f064 | 2023-10-24 | Warnings | 5W7SIA7YZW |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.